Identification and Management of Medical Comorbidities in Patients With HR+/HER2– Metastatic Breast Cancer Treated With CDK4/6 Inhibitors: Literature Review and Recommendations From Experts in Spain Opinion

Authors: Hinojo, Carmen ^{1, 2}, Cantos, Blanca ³, Antolín, Silvia ⁴, Arqueros, Cristina ⁵, Díaz-Redondo, Tamara ⁶, González, Iria ⁷, Llabrés, Elisenda ⁸, Ramírez, Javier Alonso ^{9, 10}, Barral, Manuel ¹¹, Escudero, María ⁷, Fernández, Loreto ¹², Linares, Eva Juan ⁵, López-Ibor, Jorge V. ¹³, Campo Palacio, Heidy ¹⁴, Piedra León, María ², de la Cruz, Susana ^{12, ⁎}

Source: In Clinical Breast Cancer December 2024